Bristol-Myers Squibb (HIV R&D assets)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Development of HIV medicines. The unit engages in the research and development of HIV medicines and performing pre-clinical trials and set discovery phases.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
- 345 Park Avenue
- New York, NY 10154
- United States
Bristol-Myers Squibb (HIV R&D assets) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.
Request full access to PitchBookBristol-Myers Squibb (HIV R&D assets) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.
Request full access to PitchBook